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Abstract
Background
TNF-α and IFN-γ play a role in the development of mucosal damage in celiac disease (CD).
Polymorphisms of TNFA and IFNG genes, as well as of the TNFRSF1A gene, encoding the
TNF-α receptor 1, might underlie different inter-individual disease susceptibility over a com-
mon HLA risk background. The aims of this study were to ascertain whether five SNPs in
the TNFA promoter (-1031T>C,-857C>T,-376G>A,-308G>A,-238G>A), sequence variants
of the TNFRSF1A gene and IFNG +874A>T polymorphism are associated with CD in a HLA
independent manner.
Methods
511 children (244 CD, 267 controls) were genotyped for HLA, TNFA and INFG (Real Time
PCR). TNFRSF1A variants were studied (DHPLC and sequence).
Results
Only the rare TNFA-1031C (OR=0.65, 95% CI:0.44-0.95), -857T (OR=0.42, 95% CI:0.27-
0.65), -376A (OR=2.25, 95% CI:1.12-4.51) and -308A (OR=4.76, 95% CI:3.12-7.26) alleles
were significantly associated with CD. One TNFRSF1A variant was identified (c.625+10A>G,
rs1800693), but not associated with CD. The CD-correlated TNFA SNPs resulted in six hap-
lotypes. Two haplotypes were control-associated (CCGG and TTGG) and three were CD-
associated (CCAG, TCGA and CCGA). The seventeen inferred haplotype combinations
were grouped (A to E) based on their frequencies among CD. Binary logistic regression anal-
ysis documented a strong association between CD and HLA (OR for intermediate risk haplo-
types=178; 95% CI:24-1317; OR for high risk haplotypes=2752; 95% CI:287-26387), but also
an HLA-independent correlation between CD and TNFA haplotype combination groups. The
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CD risk for patients carrying an intermediate risk HLA haplotype could be sub-stratified by
TNFA haplotype combinations.
Conclusion
TNFA promoter haplotypes associate with CD independently from HLA. We suggest that
their evaluation might enhance the accuracy in estimating the CD genetic risk.
Introduction
Celiac disease (CD), an autoimmune enteropathy, develops in genetically predisposed individ-
uals after the exposure to gluten-derived peptides [1,2]. CD patients make antibodies specific
for gluten peptides, but also for autoantigens, tissue transglutaminase (tTG) being a highly spe-
cific autoantigen, and develop enterocytes destruction by CD8+ T cells [2]. Moreover, numer-
ous innate and adaptive immune response alterations occur in both the intestinal epithelial
layer and the lamina propria, resulting in the infiltration of leukocytes, the activation of den-
dritic cells and CD4+ T cells with an increased expression, and the release of IL-15, interferon
(IFN)-γ and possibly IL-21 [3]. In the mucosa of CD patients, macrophages are also activated,
these cells being the main producers of the tumor necrosis factor (TNF)-α, another relevant cy-
tokine in CD pathogenesis [4–7].
The maintenance of the immune alterations seen in CD intestinal mucosa is strictly depen-
dent on gluten ingestion, which was demonstrated to increase TNF-α, not IFN-γ expression in
CD patients, and to increase IFN-γ, not TNF-α in “non-celiac gluten sensitivity” patients [7].
Gluten derived peptides, which undergo enzymatic deamidation by tTG, are transformed into
deamidated gluten derived peptides, which are preferentially recognized by lamina propria
CD4+ T cells in the presence of disease-associated HLA molecules [2]. The HLA locus, the
most relevant genetic factor for CD, accounts for 40 to 50% of the genetic variance occurring in
patients with the disease. The HLA-DQ2 haplotype (DQA105/DQB102, also known as
DQ2.5) is expressed in 90% of CD cases, but also in one third of the general population, while
HLA-DQ8 haplotype (DQA103/DQB10302) or another variant of HLA-DQ2 (DQA102/
DQB102, also known as DQ2.2) is expressed in about 5%. The influence of HLA on CD sus-
ceptibility shows a dose effect. Individuals can be classified as being at a high or intermediate
risk of CD on the basis of the HLA-DQ haplotype and on the number of DQB102 carrying al-
leles [8–11].
Several non-HLA genes, mainly derived from GWAS, have recently been identified as new
susceptibility factors for CD. So far, 39 loci with 57 independent association signals have been
described and overall they have been estimated to account for about 14% of the genetic vari-
ance of the disease [2]. Many of the newly discovered CD associated loci harbor genes that are
related to the immune response, particularly B and T cell function [12–14] and some polymor-
phisms that have emerged from GWAS are indirectly related to the physiology of IFN-γ and/or
TNF-α [13,15]. IFN-γ and TNF-α production might be dependent also on IFNG and TNFA
genes polymorphisms, and in particular on IFNG +874A>T and TNFA -308G>A which have
a functional significance [16–18]. Few and contrastive studies are available in literature focus-
ing on IFNG +874A>T polymorphism in CD [19,20], while some studies support the existence
of an association between CD and the TNFA -308 A allele [21–25]. Notably, it has been ob-
served that this latter association is independent of the HLA-DQ2 haplotype despite the linkage
between TNFΑ gene and HLA class II genes, both located in close proximity on the human
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chromosome 6p21.3 region [26]. Furthermore, although the TNFA -308 A allele is reported to
be correlated with a higher transcription than the G allele [26], this finding might depend solely
on the fact that the allele belongs to specific extended TNFA haplotypes [27].
TNF-α acts by binding to TNF-α receptors, mainly TNFΑ-R1 and TNFΑ-R2. Mutations in
the TNFΑ-R1 extracellular domain are associated with the auto-inflammatory TNF receptor-
associated periodic syndrome (TRAPS) but may also be involved in CD, which is included in
the autoinflammatory-autoimmune continuum [28]. The hypothesis that autoinflammation
may play a pathogenic role in CD is supported by the recent findings of Palova-Jelinkova et al.
[29], who demonstrated that the breakdown of wheat gliadin by pepsin induces a robust IL-1β
and IL-1α secretion by peripheral blood mononuclear cells through the activation of innate im-
mune pathways, including the NLRP3 inflammasome. To our knowledge, no study in the liter-
ature has investigated whether sequence variations of the TNF-α receptor gene TNFRSF1A are
associated with CD.
We hypothesized that a combined analysis of TNFA promoter haplotypes, TNFRSF1A se-
quence and of IFNG +874A>T polymorphism will allow to identify HLA-DQ2/DQ8 indepen-
dent genetic risk factors for CD. To verify this hypothesis, we thought to study the IFNG
+874A>T and five polymorphisms of the TNFA promoter (-1031T>C, -857C>T, -376G>A,
-308G>A, -238G>A) and to inspect for variants of the TNFRSF1A sequence in a large retro-
spective cohort of CD and control children.
Materials and Methods
Ethics statement
The parents of all the children gave their fully informed written consent to the study for their
offspring. The study was approved by the Local Institutional Ethic Committee (“Comitato Etico
per la Sperimentazione, Azienda Ospedaliera di Padova”, ce.sperimentazione@sanita.padova.it).
Patients
In the present retrospective cohort study, we investigated a total of 511 young patients coming
from the North East of Italy (Table 1): 198 boys (mean and median age 9 [range 4–12] years)
and 313 girls (mean and median age 9 [range 4–12]) years. All children consecutively under-
went upper gastrointestinal endoscopy for persistent abdominal symptoms. In all cases, fasting
blood for DNA and IgA tTG analyses (S1 Materials and Methods), duodenal and gastric biop-
sies for histology were taken. CD was histologically diagnosed in 244 (cases) and ruled out in
the remaining 267 children (controls). The endoscopic findings and intestinal type lesions clas-
sified following theMarsh–Oberhuber criteria for celiac lesions [30], are detailed in Table 1.
TNFA and IFNG genotyping
Genomic DNA, extracted from EDTA-K2 peripheral blood by the Qiamp DNA blood maxi kit
(QIAGEN S.p.A., Milan, Italy), was used to study IFNG +874A>T (rs2430561) and TNFA
(-1031T>C, rs1799964; -857C>T, rs1799724; -376G>A, rs1800750; -308G>A, rs1800629;
-238G>A, rs361525) polymorphisms, to detect TNFRSF1A variants and to genotype HLA. Sin-
gle nucleotide polymorphisms of IFNG and TNFA genes were assayed by real-time PCR (ABI
Prism 7900, Applied Biosystem, Foster City, CA, USA) as previously described in details [31,32].
TNFRSF1A analysis
Exons 2, 3, 4 and 6 of the TNFΑRSF1A gene were studied using denaturing high-performance
liquid chromatography (DHPLC; Wave 2100 Fragment Analysis, Transgenomic, Omaha, NE,
TNFAHaplotype and Celiac Disease in Children
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USA) and gene sequencing (ABI PRISM 3130 Genetic Analyzer, Applied Biosystem) according
to D’Osualdo et al. [33]. Details are reported in S1 File and S1 Table.
HLA genotyping
A real-time polymerase chain reaction was employed by means of Taqman probes using an
ABI Prism 7900 HT sequence detection system. Primers and probes for HLA-DQA10201,
HLA-DQA103 and HLA-DQA105 detection were described by Fernandez et al. [34]. For
HLA-DQB102 andHLA-DQB10302 alleles typing, primers were those described by
Ferstlet al. [35]. Homozygous status was evaluated for the HLA-DQB102 allele by the set up of
RT-PCR reactions to detect most of the already known HLA-DQB1 alleles different from 02
[35]. Primers and probes were aligned with sequences reported in the IMGT/HLA database
(http://www.ebi.ac.uk/ipd/imgt/hla/) and were purchased by Invitrogen Life Technologies
(Monza, Italy). The analyses were made starting with about 100 ng DNA in a final volume of
25 μl containing 1X Taqman Universal PCR Master Mix (Applied Biosystems), 900 nM prim-
ers and 250 nM probes. The thermocycling conditions were 50°C for 2 minutes, 94°C for 7
minutes, followed by 42 cycles at 92°C for 20 seconds, 60°C for 1 minute and 20 seconds.
Table 1. Patients’ details and clinicopathological characteristics.
CD Controls
Patients, n 244 267
Females, n (%) a 167 (68%) 146
(55%)
Mean age ±s.d. (years) b 7±4 10±4
Age range (years) 1–23 0.5–19
Endoscopic ﬁndings:
Normal 19 167
Esophagitis / Hiatus hernia 0 / 0 17 / 6
Antral hyperemia / Diffuse gastric hyperemia / Duodenitis 3 / 0 / 1 24 / 11 /
1
Nodularity of the antral mucosa / Antrum and corpus nodularity 4 / 0 19 / 12
Duodenal nodular mucosa with mosaic pattern / Duodenal
nodular mucosa with mosaic pattern and scalloping
149 / 68 9 / 1
Histology (Marsh-Oberhuber classiﬁcation):
No Lesions 0 262
Type 1 9 5
Type 2 16 0
Type 3 219 (3a = 34, 3b = 51,
3c = 134)
0
H. pylori infection c 12 50
Mean tTG±s.d. (Units) d 153±79 5±9
CD, celiac disease
a Chi-square test: 10.17, p = 0.001
b Student’s t test for unpaired data: t = 7.13, p<0.0001
c Chi-square test: 20.09, p<0.0001
d Student’s t test for unpaired data: t = 30.14, p<0.0001
doi:10.1371/journal.pone.0123244.t001
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Statistics
The statistical analysis of data was made by using the chi-square test, binary logistic regression
analysis, Student’s t test for unpaired data, Shapiro-Wilk W test for normal data, one way
Anova (Stata 13.1, StataCorp, Lakeway Drive, TX, USA). The Hardy-Weinberg equilibrium
test and pairwise linkage disequilibrium calculation analysis were done using Arlequin, version
2.000 (http://cmpg.unibe.ch/software/arlequin3/). Haplotypes with frequency and odds ratios
were estimated by the retrospective profile-likelihood approach (dominant model; haplologit
package; Stata 13.1) [36].
Results
In the retrospective cohort of 511 children and adolescents evaluated in this study, CD was di-
agnosed in 244 patients (cases) and ruled out in the remaining 267 (controls). Among controls
mean age was higher, female gender lower andH. pylori infection more frequent than in CD
(Table 1). Accordingly, age, gender andH. pylori infection were considered as potential con-
founding factors in all subsequent statistical analyses.
Dose effect of HLA-DQA1 andHLA-DQB1 genetics on CD susceptibility
HLA-DQ haplotypes were classified in agreement with Megiorni et al. [10] on the basis of the
combination between HLA-DQA1 and of HLA-DQB1 alleles. Table 2 shows the HLA-DQ hap-
lotypes, the corresponding HLA-DQA1 andHLA-DQB1 alleles, the number of patients bearing
each individual haplotype and its frequency in CD cases and controls. In Table 2, the Odds
Ratio (OR) and the 95% Confidence Interval (95% CI) for any HLA-DQ haplotype, calculated
with respect to HLA-DQ negative patients, are also reported together with the estimated post-
test probability of CD, considering that its reported prevalence among the general population
of children and adolescents from the same geographic area is 1:184 [37]. The HLA-DQ2.5
Table 2. HLA haplotype and CD risk.
HLA HLA-DQA1
alleles
HLA-DQB1
allelesa
Total,
Nr.
Cases, Nr.
(frequency)
Controls, Nr.
(frequency)
OR (95%CI)b p-value Adjusted
p-value
Risk of
CDc
Neg Any X/X 159 1 (0.01) 158 (0.99) Ref. - - 1:18216
DQ8 *03/any *0302/X 24 7 (0.29) 17 (0.71) 83 (9–742) <0.0001 <0.0001 1:450
B2, hetero *05 neg *02/X 27 8 (0.30) 19 (0.70) 63 (7–547) <0.0001 <0.0001 1:429
DQ8/
B1*02 pos
*03/*05 neg *0302/*02 8 3 (0.37) 5 (0.63) 104 (8–1375) <0.0001 <0.0001 1:313
DQ2.5
hetero
*05/any *02/X 162 104 (0.64) 58 (0.36) 284 (38–2107) <0.0001 <0.0001 1:103
DQ2/DQ8 *03/*05 *0302/*02 14 10 (0.71) 4 (0.29) 585 (52–6523) <0.0001 <0.0001 1:75
B2, homo *05 neg *02/*02 9 7 (0.78) 2 (0.22) 664 (50–8790) <0.0001 <0.0001 1:52
DQ2.5 homo *05/any *02/*02 108 104 (0.96) 4 (0.04) 4422
(474–41281)
<0.0001 <0.0001 1:7
p values in boldface are signiﬁcant
aX = any HLA-DQB1 allele different from *02 or *0302
bOR = Odds Ratio; 95%CI = 95% Conﬁdence Intervals. Odds Ratios were calculated by binary logistic regression analysis adjusted for age, gender and
H. pylori infection
c Risk of CD is expressed as 1:N, where N is the number of individuals among which one case is present. Considering a disease prevalence of 1:184 in
the general population [37], for each HLA-DQ category, N is calculated as a percentage of controls with that particular HLA-DQ status multiplied by 184
and divided by percentage of patients with the same DQ typing [10].
doi:10.1371/journal.pone.0123244.t002
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homozygous haplotype was associated with the highest risk of CD (1:7). Interestingly, the ho-
mozygous HLA-DQB102 allele alone increased CD risk to levels comparable with those of
HLA-DQ2.5 heterozygotes, while HLA-DQ8 had only a modest effect on CD risk (1:450).
TNFA, not IFNG and TNFRSF1A polymorphisms, are associated with
CD
Table 3 reports the results of the studied polymorphisms of TNFA and IFNG genes. Consider-
ing each individual single nucleotide polymorphism (SNP), the minor allele frequency (MAF),
the number and frequency of genotypes in cases and controls are shown. To ascertain whether
minor alleles exert any effect on CD risk, we estimated the OR with 95% CI associated with
dominant and recessive models (Table 3). With the exception of the TNFA -238G>A, all the
studied TNFA SNPs were correlated with a diagnosis of CD, and all the rare alleles had a domi-
nant effect on CD risk. The IFNG+874A>T polymorphism was not correlated with CD.
Interestingly H. pylori infection was associated with IFNG +874A>T (dominant model: chi-
square = 4.73, p = 0.030), not with the other polymorphisms.
Table 3. TNFA, IFNG and TNFRSF1A gene polymorphisms in CD.
Gene dbSNP MAFa Genotypes Cases b Controls c Dominant model Recessive model
n (freq) n (freq) p-value (2df) ORd(95%CI) p-value (2df) ORd(95%CI)
TNFA -1031T>C C (0.027) C/C 9 (0.04) 22 (0.08) 0.027 0.65(0.44–0.95) 0.042 0.41 (0.17–0.97)
T/C 73 (0.30) 97 (0.36)
T/T 162 (0.66) 148 (0.56)
-857C>T T (0.153) T/T 3 (0.01) 8 (0.03) <0.0001 0.42 (0.27–0.65) 0.316 0.48 (0.12–2.01)
C/T 45 (0.19) 89 (0.33)
C/C 196 (0.8) 170 (0.64)
-376G>A A (0.047) A/A 2 (0.01) 0 (-) 0.023 2.25 (1.12–4.51) - -
G/A 28 (0.11) 16 (0.06)
G/G 214 (0.88) 251 (0.94)
-308G>A A (0.216) A/A 20 (0.08) 3 (0.01) <0.0001 4.76 (3.12–7.26) 0.001 10.09 (2.71–37.55)
G/A 117 (0.48) 58 (0.22)
G/G 107 (0.44) 206 (0.77)
-238G>A A (0.068) A/A 2 (0.01) 1 (0.01) 0.241 1.41 (0.80–2.46) 0.841 1.28 (0.11–14.67)
G/A 34 (0.14) 29 (0.11)
G/G 208 (0.85) 237 (0.88)
IFNG +874A>T T (0.458) T/T 52 (0.21) 56 (0.21) 0.929 0.98 (0.65–1.48) 0.810 1.06 (0.67–1.68)
A/T 116 (0.48) 136 (0.51)
A/A 76 (0.31) 75 (0.28)
TNFRSF1A c.625+10A>G A (0.363) G/G 17 (0.33) 26 (0.39) 0.739 1.16 (0.47–2.76) 0.061 0.21 (0.04–1.07)
G/A 32 (0.63) 31 (0.47)
A/A 2 (0.04) 9 (0.14)
p values in boldface are signiﬁcant
aMAF = minor allele frequency
bCases: n = 244; n = 51 for TNFRSF1A
cControls: n = 267; n = 66 for TNFRSF1A
dOR = Odds Ratio; 95%CI = 95% Conﬁdence Intervals. Odds Ratios were calculated by binary logistic regression analysis adjusted for age, gender and
H. pylori infection.
doi:10.1371/journal.pone.0123244.t003
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In a first series of 16 CD and 14 controls, exons 2-3-4-6 and the flanking intronic DNA se-
quences of the TNFRSF1A gene were screened by DHPLC to identify the presence of DNA se-
quence variants (heteroduplex). No variants were found on considering exons 2-3-4 and the
adjacent intronic regions. Since in 9 CD and in 4 controls DHPLC analysis revealed the pres-
ence of a variant within amplicons spanning exon 6 and adjacent intronic regions, these re-
gions were analyzed by DHPLC in a further series of 35 cases and 52 controls. At DNA
sequence analysis, all variant samples were found to carry intronic c.625+10A>G (rs1800693)
polymorphism. In our series of patients, differently from what reported in the dbSNP database
(http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=1800693) (last accessed: 30th Janu-
ary 2015), the minor allele was the c.625+10G, not the c.625+10A. This TNFRSF1A polymor-
phism was not correlated with a diagnosis of CD (Table 3).
The findings made on ascertaining whether any of the studied TNFΑ, IFNG and TNFRSF1A
polymorphisms were associated with the HLA-DQ haplotypes are shown in S2 Table. Three
polymorphisms (-857C>T, -376G>A and -308G>A) of TNFΑ gene were associated with
HLA-DQ haplotypes, whereas the remaining two TNFA(-1031C>T and -238G>A), IFNG
+874A>T and TNFRSF1A c.625+10A>G polymorphisms were not. Multivariate binary logis-
tic regression analyses were then made considering CD diagnosis as outcome variable, while
HLA-DQ haplotypes, the carriage of TNFA and IFNG rare alleles in homozygosis (recessive ef-
fect) or in heterozygosis (dominant effect) were predictor variables (S3 Table). The reduction
in the risk of CD by the TNFA -1031 A rare allele and the increase by the TNFA-308 Α rare al-
lele occurred independent of HLA-DQ haplotype effects.
TNFA haplotypes are HLA-independent risk factors for CD
The studied polymorphisms of the TNFA, all closely located in the gene promoter region, are
carried as different haplotypes. We therefore determined the haplotypes resulting from the
combination of TNFA-1031T>C,-857C>T,-376G>A and -308G>A polymorphisms, which
were singly correlated with CD diagnosis. A total of six haplotypes with an overall frequency
above 10-5 were found: their relative frequencies in CD cases and controls and the OR with
95% CI with respect to the most frequent haplotype (CCGG) are reported in S4 Table. For a
clearer reading of subsequent results, the six haplotypes were coded as H1 to H6. TNFA haplo-
types combinations were then estimated for any studied subject: a total of 17 haplotype combi-
nations were inferred and are shown together with their frequencies in CD and controls in S5
Table (chi-square = 103, p<0.0001). The H1/H1 and H1/H2 combinations were rare among
CD cases (<6%) and frequent among controls (>94%), while the inverse was observed for the
H4/H5 and H5/H5 combinations (>80% among CD and<14% among controls). The rare
H4/H4, H6/H6 and H3/H6 were exclusive to CD. The frequency of the remaining haplotype
combinations ranged from 27 to 72% among CD and 31 to 73% among controls. On the basis
of the frequency recorded among CD cases, haplotypes combinations were grouped as follows:
group A (frequency among CD<10%); group B (10–40%); group C (40–60%); group D (60–
80%); group E (>80%). TNFA haplotype combinations groups were correlated with the
HLA-DQ haplotypes (chi-square = 190, p<0.0001). In particular, group A was strongly associ-
ated with HLA-DQ negativity, whereas group E strongly associated with HLA-DQ2.5 homozy-
gotes (S1 Fig).
Table 4 shows the results obtained on ascertaining whether TNFA haplotype combinations
exerted an independent effect on CD risk by performing multivariate binary logistic regression
analysis adjusted for age, gender andH. pylori infection and considering CD diagnosis as an
outcome variable, HLA-DQ haplotypes and TNFΑ haplotype combinations as predictors.
TNFΑ haplotype combinations play an independent role in enhancing CD risk, although the
TNFAHaplotype and Celiac Disease in Children
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ROC curve area obtained using the logistic regression model including as predictors HLA-DQ
haplotypes, age, gender andH. pylori infection was not significantly different from the model
that also included the TNFA haplotype combinations (p = 0.104) (S2 Fig). The multivariate bi-
nary logistic regression model presented in Table 4 was used to estimate the marginal probabil-
ity of CD on the basis of HLA-DQ and TNFA haplotype combinations (Fig 1). The probability
of CD was confirmed to be dependent on TNFA haplotype combinations mainly in the subset
of patients carrying HLA-DQ intermediate risk haplotypes, which included HLA-DQ8, HLA-
B2 hetero, HLA-DQ8/B102 pos, HLA-DQ2.5 hetero, HLA-DQ2/DQ8 and HLA-B2 homo.
TNFA haplotypes and CD histology
We verified whether HLA-DQ and TNFA genetics correlate with CD histology. Patients were
classified on the basis of the presence or absence of total atrophy [38]. HLA-DQ haplotype
was not significantly correlated with total atrophy, which was found in 64/104 (61.5%)
HLA-DQ2.5 homozygotes and in 70/140 (50.0%) remaining CD patients (Odds ratio = 1.6,
95%CI = 0.92–2.77; p-value = 0.073). The risk of total atrophy was stratified for TNFA haplo-
type combinations groups A to E considering CD patients carrying a high (HLA-DQ2.5 homo-
zygous) or intermediate risk HLA-DQ haplotypes. A significant decrease of the risk of total
atrophy was found in the intermediate risk HLA-DQ group (OR = 0.72, 95% CI = 0.52–0.99,
p = 0.048), but not in HLADQ2.5 homozygotes (OR = 0.99, 95% CI = 0.67–1.44, p = 0.941).
Serum TNF-α increases in CD and associates with TNFRSF1A, not with
TNFA genetics
We then verified whether serum TNF-α levels are influenced by CD presence and/or TNFA/
TNFRSF1Α genetics. Serum TNF-α was measured in 52 cases and in 50 controls. Due to
asymmetrical distribution (Shapiro-Wilk W test for normal data: p<0.0001), the variable was
transformed to 1/square root. Although serum TNF-α values were significantly higher in CD
patients than in controls (Student’s t test: t = 4.32, p<0.0001) (Fig 2, upper panel), they were not
Table 4. Binary logistic regression analysis.
ORa 95%CI p-value Adjusted p-valueb
HLA-DQ haplotype:
Neg Ref
Intermediate riskc haplotypesc 178 24–1317 <0.0001 <0.0001
DQ2.5 homo 2752 287–26387 <0.0001 <0.0001
TNFA haplotype: combinations
Group A Ref
Group B 5 1–28 0.049 0.490
Group C 11 2–65 0.011 0.110
Group D 13 2–70 0.003 0.030
Group E 13 2–104 0.016 0.160
Constant 0.0055 0.0004–0.07 <0.0001 -
Outcome variable: CD diagnosis; Predictor variables: HLA-DQ haplotypes, TNFA haplotype combinations.
p values in boldface are signiﬁcant
a OR = Odds Ratio; Odds Ratios were calculated by binary logistic regression analysis adjusted for age, gender and H. pylori infection
bBonferroni’s adjusted p-values for multiple testing
cHLA-Q8, HLA-B2 hetero, HLA-DQ8/B1*02 pos, HLA-DQ2.5 hetero, HLA-DQ2/DQ8, HLA-B2 homo.
doi:10.1371/journal.pone.0123244.t004
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associated with any TNFA studied polymorphisms considered singly or as haplotypes (F = 0.98,
p = 0.422). Interestingly, the circulating levels of TNF-α tended to be higher in CD patients car-
rying the TNFRSF1AA allele (one way Anova: F = 2.55, p = 0.0742; Fig 2, lower panel).
Discussion
In the year 2012, the European Society for Pediatric Gastroenterology, Hepatology, and
Nutrition formulated new guidelines for the diagnosis of CD in the pediatric age [39]. One al-
gorithm was developed for symptomatic, and another for asymptomatic children and adoles-
cents at an increased risk of developing the disease. In the former algorithm, positive findings
for HLA-DQ2 or HLA-DQ8 are confirmatory for CD diagnosis in symptomatic children and
adolescents with positive anti-tTG2 (10x normal) and EMA, while in the latter algorithm
HLA-DQ2 or HLA-DQ8 testing is proposed as the initial action to identify negative patients
who can be excluded from further studies. However, in patients positive at HLA-DQA1 and
HLA-DQB1 typing, the CD risk depends on the resulting haplotype, spanning from very high
(about 1:10 for HLA-DQ2.5) to low risk values (about 1:200 for B102/X), the latter being
Fig 1. HLA-DQ and TNFA haplotype combinations predict CD risk. The marginal probability of CD was estimated on the basis of the multivariate binary
logistic regression model reported in Table 4 adjusted for age, gender and H. pylori infection. Reference was the group of patients with negative HLA-DQ and
TNFA group A haplotype combination. Dots and bars represent the estimated CD probability with their respective Bonferroni’s adjusted standard errors.
*: p<0.05 for all groups with respect to TNFAGroup A and p<0.05 for TNFAGroup D with respect to TNFAGroup B (pairwise comparisons of marginal linear
predictions).
doi:10.1371/journal.pone.0123244.g001
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similar to that of the general population [10,37]. The findings made in the present study con-
firm the presence of a risk gradient for CD associated with the HLA-DQ haplotype resulting
fromHLA-DQA1 and HLA-DQB1 allele combinations: the HLA-DQ8 haplotype or the pres-
ence ofHLA-DQB102 allele in single dose and not associated withHLA-DQA105 allele repre-
sent modest risk factors for CD, while the probability of developing the disease progressively
increases as the number of HLA-DQB102 andHLA-DQA105 alleles increases, the highest
risk (1:7) being found among HLA-DQ2.5 homozygotes. This high risk HLA-DQ haplotype
was recently demonstrated to be the only factor that was significantly associated with the devel-
opment of CD autoimmunity and overt CD in children who had at least one first-degree affect-
ed relative [40]. Since in our series of patients only few cases carried a single or double copy
of the DQB102 allele associated with DQA1 alleles different from DQA105 or carried the
HLA-DQ8, in agreement with Lionetti et al. [40], our studied children were classified as having
no HLA-DQ risk alleles, a high risk (HLA-DQ2.5 Homo) and an intermediate risk HLA-DQ
Fig 2. TNFRSF1A polymorphism affects serum TNF-α levels. Serum TNF-α in controls and CD patients
(upper panel) and in patients subdivided according to the TNFRSF1Ac.625+10A>G (rs1800693)
polymorphism (lower panel).
doi:10.1371/journal.pone.0123244.g002
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haplotype, the latter including all together DQ8, B2 hetero, DQ8/B102 pos, DQ2.5 hetero,
DQ2/DQ8 and B2 homo. From a pathophysiological viewpoint, the diversity in genetic suscep-
tibility associated with different HLA-DQ haplotypes is probably due, at least in part, to the
recognition of different gluten peptide repertoires affecting T cell activation [9]. From a practi-
cal clinical viewpoint this diversity raises the question of whether a different management
should be proposed for asymptomatic patients carrying high risk or intermediate risk
HLA-DQ haplotypes. More specifically, the identification of HLA-DQ independent genetic
risk or protective factors for CD might improve our understanding of the disease and amelio-
rate risk stratification of patients. We focused our study on one HLA-associated gene, TNFA
[26], and on two non-HLA-associated genes, IFNG and TNRFSF1A [32,33], whose protein
products play an active role in the pathophysiology of CD. TNF-α and IFN-γ are known to
play an active role in CD, but also in refractory CD [41], and sequence variations of the main
TNF-α receptor, TNF-R1, caused by mutations of the encoding TNRFSF1A gene, may deter-
mine an altered cellular response to TNF-α stimulation [42].
IFNG +874A>T polymorphism was not associated with CD, but it was associated withH. py-
lori, thus further supporting the role of IFN-γ genetics in infectious diseases [32]. Four of the
five TNFA promoter polymorphisms were found to be correlated with a diagnosis of CD: the
rare alleles of the -1031T>C and -857C>T had a protective dominant effect, while the rare al-
leles of the -376G>A and -308G>A enhanced the risk of CD. The TNFA-308 A allele had an ad-
ditional effect on CD risk, unlike the -376A allele; this difference is probably due to the fact that
the latter minor allele frequency is very low (0.047) while the former is not (0.216). Since the
TNFA gene is located in close proximity of the HLA class II region, we ascertained whether
TNFA genotypes were associated with HLA-DQ haplotypes, and this occurred for the -857C>T,
-376G>A and -308G>A, not for the -1031T>C, polymorphisms. To ascertain whether the
TNFA-associated risk for CD is dependent or independent from its linkage with theHLA-DQA1
and—B1 genes, multivariate statistical analysis was performed, including as cofactors the poten-
tial confounders age, gender andH. pylori infection which was less frequently found among CD
patients than in controls. The rare TNFA-1031 A and -308 A alleles were confirmed to be
HLA-DQ independent CD-associated variants: carriers of the -1031 A allele in homozygosis
have a reduced risk, while carriers of the -308 A allele have about a 3 fold increased risk of CD,
this finding being in agreement with previously reported data in the literature [21,22,24].
To obtain further insight on the association between TNFA genetics and CD, our subsequent
analysis of data was focused on TNFA haplotypes. Although any single polymorphism might in-
fluence gene transcription to different extents, in the presence of a string of SNPs located in
close proximity with each other, their different combinations in haplotypes might reinforce or
otherwise revert the effects on gene transcription of any single SNP. We considered the four
TNFA SNPs significantly associated with CD (-1031T>C, -857C>T, -376G>A and -308G>A)
and, using the Arlequin statistical software, estimated the haplotypes resulting from their com-
binations. Two of the six possible obtained haplotypes were more frequent among controls, the
CCGG (H1) and TTGG (H2), three were more frequent among CD cases, the CCAG (H4),
TCGA (H5) and CCGA (H6) haplotypes, while the frequency of the TCGG (H3) haplotype was
similar in CD and controls. Since diploid cells carry pairs of haplotypes, we estimated the possi-
ble combinations resulting fromH1–H6 haplotypesin our patients, and found 17 combinations.
To reduce data dispersion five classes of haplotype combinations (groups A to D) were identi-
fied on the basis of their frequency among CD: very low (<10%), low (10–40%), intermediate
(40–60%), high (60–80%) and very high (>80%). Haplotype combinations were confirmed to
be correlated with CD diagnosis; although all TNFA haplotype combinations groups B to E in-
creased CD risk with respect to group A, an HLA-DQ independent statistically significant effect
was found for Group D with respect to group A. In the attempt to translate these findings in
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clinical practice, we verified whether TNFA haplotype combinations might improve risk estima-
tion among the three HLA-DQ identified categories: HLA-DQ negative, HLA-DQ2.5 homozy-
gotes and intermediate risk HLA-DQ. In the absence of HLA-DQ risk alleles, the TNFA
haplotype did not modify the predicted CD risk. Vice versa in HLA-DQ high risk, but mainly in
intermediate HLA-DQ risk subjects, carriage of any TNFA haplotype different from group A in-
creased the predicted probability of disease and this increase appeared to be progressively higher
in groups from B to E. Therefore TNFA genetic testing might be suggested as being of some help
in improving CD risk assessment and in further studying patients. Interestingly, while HLA-DQ
was not significantly associated with the histopathological lesion severity, in agreement with
Ruiz-Ortiz et al. [43], TNFA haplotype A to E showed a negative trend of association with sever-
ity of lesions. In other words, the progressive increase in CD risk due to TNFA haplotypes is as-
sociated with a progressive less severe histopathology. If confirmed, this finding indicates that
patients carrying high risk TNFA haplotypes are at risk of a less severe mucosal damage with a
consequent uncertainty in the histological diagnosis [44].
In order to ascertain whether TNFA haplotypes influence TNF-α protein levels, we mea-
sured this cytokine in a series of case and control sera. Serum TNF-α values were higher in CD
patients than in controls, supporting the role of TNF-α in CD, but they were not correlated
with TNFA haplotypes. Although these findings argue against the hypothesis that TNFA haplo-
types increase CD risk by enhancing TNF-α production, we cannot rule out that they affect the
amount of TNF-α produced in the affected duodenal mucosa microenvironment.
One of the main TNF-α receptors mediating its the inflammatory effect is TNF-R1, encoded
by the TNFRSF1A gene [45]. The R92Q polymorphism of this gene has been associated with an
increased risk of TRAPS [46]. Due to the relevant impact of TNF-α on CD pathogenesis, we
verified whether the TNFRSF1A gene had any variant correlated with CD. Only one polymor-
phism of this gene was identified in our series of cases and controls, the c.625+10A>G
(rs1800693), which is reportedly a risk factor for multiple sclerosis [47]. The lack of any associ-
ation between this polymorphism and CD allows us to rule out the hypothesis that it takes a
part in causing duodenal atrophy upon exposure to gluten peptides. However, in CD patients
this SNP was associated with slightly increased serum TNF-α levels. This might be due to an al-
tered TNF-α/TNF-R1 balance consequent to the synthesis of a truncated TNF-R1 in patients
carrying this polymorphism, as previously demonstrated by Ottoboniet al. [48].
In this study we have demonstrated that extended TNFA promoter haplotypes are HLA-DQ
independent risk factors for CD and that their analysis might enhance the reliability in estimat-
ing the risk of CD especially in patients carrying an intermediate risk HLA-DQ haplotype. The
strength of our principal findings rely upon the large number of patients with the same ethnici-
ty entered the study. This renders our results transferrable within European populations, but
require confirmation in populations that have a different LD structure, like Africans, Japanese
or Chinese. The extended analysis of other genetic loci reportedly associated with CD by
GWAS, which will be fast and cost-effective by the incoming high-throughput technology, rep-
resents a focus for future research.
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